{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:45:07Z","timestamp":1778546707464,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T00:00:00Z","timestamp":1556582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Carolinas Muscular Dystrophy Research Endowment"},{"DOI":"10.13039\/100008156","name":"Carolinas HealthCare Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008156","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Carolinas Medical Center"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.omtn.2019.04.023","type":"journal-article","created":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T00:43:30Z","timestamp":1556844210000},"page":"663-674","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Aminoglycoside Enhances the Delivery of Antisense Morpholino Oligonucleotides In\u00a0Vitro and in mdx Mice"],"prefix":"10.1016","volume":"16","author":[{"given":"Mingxing","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sapana N.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peijuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qilong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2019.04.023_bib1","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/sj.embor.7400221","article-title":"Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment","volume":"5","author":"Nowak","year":"2004","journal-title":"EMBO Rep."},{"key":"10.1016\/j.omtn.2019.04.023_bib2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bbadis.2006.06.009","article-title":"Current treatment of adult Duchenne muscular dystrophy","volume":"1772","author":"Wagner","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omtn.2019.04.023_bib3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1001\/jamaneurol.2015.3537","article-title":"Identifying Non-Duchenne Muscular Dystrophy-Positive and False Negative Results in Prior Duchenne Muscular Dystrophy Newborn Screening Programs: A Review","volume":"73","author":"Gatheridge","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.omtn.2019.04.023_bib4","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.23528","article-title":"Evidence-based path to newborn screening for Duchenne muscular dystrophy","volume":"71","author":"Mendell","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtn.2019.04.023_bib5","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1126\/science.aad5725","article-title":"Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy","volume":"351","author":"Long","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.omtn.2019.04.023_bib6","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1011367","article-title":"Systemic administration of PRO051 in Duchenne\u2019s muscular dystrophy","volume":"364","author":"Goemans","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtn.2019.04.023_bib7","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S1474-4422(09)70211-X","article-title":"Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study","volume":"8","author":"Kinali","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.omtn.2019.04.023_bib8","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/nm897","article-title":"Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse","volume":"9","author":"Lu","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2019.04.023_bib9","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1073\/pnas.0406700102","article-title":"Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles","volume":"102","author":"Lu","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2019.04.023_bib10","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/ana.23982","article-title":"Eteplirsen for the treatment of Duchenne muscular dystrophy","volume":"74","author":"Mendell","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtn.2019.04.023_bib11","doi-asserted-by":"crossref","first-page":"14814","DOI":"10.1073\/pnas.0805676105","article-title":"Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer","volume":"105","author":"Wu","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2019.04.023_bib12","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/mt.2009.38","article-title":"Octa-guanidine morpholino restores dystrophin expression in cardiac and skeletal muscles and ameliorates pathology in dystrophic mdx mice","volume":"17","author":"Wu","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2019.04.023_bib13","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/gt.2009.120","article-title":"Dose-dependent restoration of dystrophin expression in cardiac muscle of dystrophic mice by systemically delivered morpholino","volume":"17","author":"Wu","year":"2010","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtn.2019.04.023_bib14","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ajpath.2012.04.006","article-title":"Long-term rescue of dystrophin expression and improvement in muscle pathology and function in dystrophic mdx mice by peptide-conjugated morpholino","volume":"181","author":"Wu","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtn.2019.04.023_bib15","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1093\/hmg\/ddn293","article-title":"Cell-penetrating peptide-conjugated antisense oligonucleotides restore systemic muscle and cardiac dystrophin expression and function","volume":"17","author":"Yin","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2019.04.023_bib16","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.addr.2015.03.008","article-title":"Antisense oligonucleotides in therapy for neurodegenerative disorders","volume":"87","author":"Evers","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.omtn.2019.04.023_bib17","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(11)60756-3","article-title":"Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study","volume":"378","author":"Cirak","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.omtn.2019.04.023_bib18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/mt.2010.261","article-title":"Chronic systemic therapy with low-dose morpholino oligomers ameliorates the pathology and normalizes locomotor behavior in mdx mice","volume":"19","author":"Malerba","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2019.04.023_bib19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1089\/oli.1.1997.7.187","article-title":"Morpholino antisense oligomers: design, preparation, and properties","volume":"7","author":"Summerton","year":"1997","journal-title":"Antisense Nucleic Acid Drug Dev."},{"key":"10.1016\/j.omtn.2019.04.023_bib20","first-page":"1","article-title":"New antisense strategies: chemical synthesis of RNA oligomers","volume":"249","author":"Yano","year":"2012","journal-title":"Adv. Polym. Sci."},{"key":"10.1016\/j.omtn.2019.04.023_bib21","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/mt.2012.236","article-title":"Polyethylenimine-modified pluronics (PCMs) improve morpholino oligomer delivery in cell culture and dystrophic mdx mice","volume":"21","author":"Wang","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2019.04.023_bib22","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1089\/hum.2013.156","article-title":"Evaluation of Tris[2-(acryloyloxy)ethyl]isocyanurate cross-linked polyethylenimine as antisense morpholino oligomer delivery vehicle in cell culture and dystrophic mdx mice","volume":"25","author":"Wang","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2019.04.023_bib23","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1039\/C5TB00139K","article-title":"Tween 85 grafted PEIs enhanced delivery of antisense 2\u2032-O-methyl phosphorothioate oligonucleotides in\u00a0vitro and in dystrophic mdx mice","volume":"3","author":"Wang","year":"2015","journal-title":"J.\u00a0Mater. Chem. B Mater. Biol. Med."},{"key":"10.1016\/j.omtn.2019.04.023_bib24","doi-asserted-by":"crossref","first-page":"5635","DOI":"10.2147\/IJN.S89910","article-title":"Cationic polyelectrolyte-mediated delivery of antisense morpholino oligonucleotides for exon-skipping in\u00a0vitro and in mdx mice","volume":"10","author":"Wang","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.omtn.2019.04.023_bib25","doi-asserted-by":"crossref","first-page":"164ra160","DOI":"10.1126\/scitranslmed.3005054","article-title":"Dantrolene enhances antisense-mediated exon skipping in human and mouse models of Duchenne muscular dystrophy","volume":"4","author":"Kendall","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtn.2019.04.023_bib26","doi-asserted-by":"crossref","first-page":"e329","DOI":"10.1038\/mtna.2016.46","article-title":"Fructose Promotes Uptake and Activity of Oligonucleotides With Different Chemistries in a Context-dependent Manner in mdx Mice","volume":"5","author":"Cao","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2019.04.023_bib27","doi-asserted-by":"crossref","first-page":"10981","DOI":"10.1038\/ncomms10981","article-title":"Hexose enhances oligonucleotide delivery and exon skipping in dystrophin-deficient mdx mice","volume":"7","author":"Han","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2019.04.023_bib28","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.omtn.2018.02.004","article-title":"Saponins as Natural Adjuvant for Antisense Morpholino Oligonucleotides Delivery in\u00a0Vitro and in mdx Mice","volume":"11","author":"Wang","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2019.04.023_bib29","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1126\/science.1176950","article-title":"Functional characterization of the antibiotic resistance reservoir in the human microflora","volume":"325","author":"Sommer","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.omtn.2019.04.023_bib30","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1128\/AAC.43.4.727","article-title":"Aminoglycosides: activity and resistance","volume":"43","author":"Mingeot-Leclercq","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.omtn.2019.04.023_bib31","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1128\/CMR.05041-11","article-title":"Combination therapy for treatment of infections with gram-negative bacteria","volume":"25","author":"Tamma","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.omtn.2019.04.023_bib32","series-title":"Aminoglycosides. UpToDate","author":"Drew","year":"2018"},{"key":"10.1016\/j.omtn.2019.04.023_bib33","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1080\/20469047.2017.1408738","article-title":"Reviewing the WHO guidelines for antibiotic use for sepsis in neonates and children","volume":"38","author":"Fuchs","year":"2018","journal-title":"Paediatr. Int. Child Health"},{"key":"10.1016\/j.omtn.2019.04.023_bib34","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1128\/AAC.7.6.811","article-title":"Antibiotic G418, a new micrommomospora-produced aminglycoside with activity against protozoa and helminths: antiparasitic activity","volume":"7","author":"Loebenberg","year":"1975","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.omtn.2019.04.023_bib35","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1001\/archderm.140.10.1241","article-title":"Contact sensitivity in patients with leg ulcerations: a North American study","volume":"140","author":"Saap","year":"2004","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.omtn.2019.04.023_bib36","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1016\/S0968-0896(01)00034-7","article-title":"Aminoglycoside binding to human and bacterial A-Site rRNA decoding region constructs","volume":"9","author":"Ryu","year":"2001","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.omtn.2019.04.023_bib37","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/mus.10341","article-title":"Gentamicin fails to increase dystrophin expression in dystrophin-deficient muscle","volume":"27","author":"Dunant","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.omtn.2019.04.023_bib38","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/1756285610388693","article-title":"Aminoglycoside-induced mutation suppression (stop codon readthrough) as a therapeutic strategy for Duchenne muscular dystrophy","volume":"3","author":"Malik","year":"2010","journal-title":"Ther. Adv. Neurol. Disorder."},{"key":"10.1016\/j.omtn.2019.04.023_bib39","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.braindev.2004.09.014","article-title":"A novel approach to identify Duchenne muscular dystrophy patients for aminoglycoside antibiotics therapy","volume":"27","author":"Kimura","year":"2005","journal-title":"Brain Dev."},{"key":"10.1016\/j.omtn.2019.04.023_bib40","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4137\/PMC.S2381","article-title":"Aminoglycosides: molecular insights on the recognition of RNA and aminoglycoside mimics","volume":"3","author":"Chittapragada","year":"2009","journal-title":"Perspect. Medicin. Chem."},{"key":"10.1016\/j.omtn.2019.04.023_bib41","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1126\/science.274.5291.1367","article-title":"Structure of the A site of Escherichia coli 16S ribosomal RNA complexed with an aminoglycoside antibiotic","volume":"274","author":"Fourmy","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.omtn.2019.04.023_bib42","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1006\/jmbi.1996.0526","article-title":"RNA sequence determinants for aminoglycoside binding to an A-site rRNA model oligonucleotide","volume":"262","author":"Recht","year":"1996","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.omtn.2019.04.023_bib43","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1387-3806(99)00111-6","article-title":"Studying aminoglycoside antibiotic binding to HIV-1 TAR RNA by electrospray ionization mass spectrometry","volume":"193","author":"Sannes-Lowery","year":"1999","journal-title":"Int. J. Mass Spectrom."},{"key":"10.1016\/j.omtn.2019.04.023_bib44","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1021\/bi962095g","article-title":"Specificity of aminoglycoside binding to RNA constructs derived from the 16S rRNA decoding region and the HIV-RRE activator region","volume":"36","author":"Wang","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.omtn.2019.04.023_bib45","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0022-2836(92)91043-O","article-title":"Non-competitive inhibition of group I intron RNA self-splicing by aminoglycoside antibiotics","volume":"226","author":"von Ahsen","year":"1992","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.omtn.2019.04.023_bib46","doi-asserted-by":"crossref","first-page":"6155","DOI":"10.1073\/pnas.96.11.6155","article-title":"Inhibition of RNase P RNA cleavage by aminoglycosides","volume":"96","author":"Mikkelsen","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2019.04.023_bib47","doi-asserted-by":"crossref","first-page":"14788","DOI":"10.1074\/jbc.M212830200","article-title":"Inhibition of transfer messenger RNA aminoacylation and trans-translation by aminoglycoside antibiotics","volume":"278","author":"Corvaisier","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2019.04.023_bib48","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1039\/B712690P","article-title":"Designer aminoglycosides: the\u00a0race to develop improved antibiotics and compounds for the treatment of human genetic diseases","volume":"6","author":"Hainrichson","year":"2008","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.omtn.2019.04.023_bib49","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/mt.2009.320","article-title":"Guanine analogues enhance antisense oligonucleotide-induced exon skipping in dystrophin gene in\u00a0vitro and in\u00a0vivo","volume":"18","author":"Hu","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2019.04.023_bib50","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1093\/nar\/29.19.3965","article-title":"Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs","volume":"29","author":"Sazani","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2019.04.023_bib51","doi-asserted-by":"crossref","first-page":"12374","DOI":"10.1021\/ja0360135","article-title":"Cellular uptake of aminoglycosides, guanidinoglycosides, and poly-arginine","volume":"125","author":"Luedtke","year":"2003","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.omtn.2019.04.023_bib52","doi-asserted-by":"crossref","first-page":"9818","DOI":"10.1021\/ja050918w","article-title":"Conformational constraint as a means for understanding RNA-aminoglycoside specificity","volume":"127","author":"Blount","year":"2005","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.omtn.2019.04.023_bib53","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1172\/JCI7866","article-title":"Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice","volume":"104","author":"Barton-Davis","year":"1999","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtn.2019.04.023_bib54","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S1074-5521(02)00153-9","article-title":"Crystal structure of a complex between the aminoglycoside\u00a0tobramycin and an oligonucleotide containing the ribosomal decoding a site","volume":"9","author":"Vicens","year":"2002","journal-title":"Chem. Biol."},{"key":"10.1016\/j.omtn.2019.04.023_bib55","doi-asserted-by":"crossref","first-page":"5677","DOI":"10.1093\/nar\/gki862","article-title":"Crystal structures of complexes between aminoglycosides and decoding A site oligonucleotides: role of the number of rings and positive charges in the specific binding leading to miscoding","volume":"33","author":"Fran\u00e7ois","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2019.04.023_bib56","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/1804","article-title":"Solution structure of the tobramycin-RNA aptamer complex","volume":"5","author":"Jiang","year":"1998","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.omtn.2019.04.023_bib57","doi-asserted-by":"crossref","first-page":"8734","DOI":"10.1021\/ja9715105","article-title":"Electrostatic Interactions in RNA Aminoglycosides Binding","volume":"119","author":"Wang","year":"1997","journal-title":"J.\u00a0Am. Chem. Soc."}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253119300964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253119300964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T01:50:43Z","timestamp":1720576243000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253119300964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":57,"alternative-id":["S2162253119300964"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2019.04.023","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aminoglycoside Enhances the Delivery of Antisense Morpholino Oligonucleotides In\u00a0Vitro and in mdx Mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2019.04.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s).","name":"copyright","label":"Copyright"}]}}